The levels of AD biomarkers, including Aβ42, P-tau 181, P-tau 199, P-tau 231, P-tau 396, and T-tau in CSF were compared between AD-OSA-M and AD-OSA-MS groups. The gene discussed is MAPT; the disease is obstructive sleep apnea syndrome.